On this page
This entry or formulation may be investigational and may not correspond to an FDA-approved product; safety and efficacy may not have been established. Kairo lists it for identification and record-keeping only.
Overview
Product & regulatory status
The evidence here concerns specific fatigue-related conditions, not a validated general productivity aid.
What the evidence shows
Placebo comparison in neurasthenia
A randomized blinded study reported improvement in asthenic symptoms relative to placebo. The accessible abstract provides limited quantitative detail, so it should not be treated as a precise estimate of benefit for everyone with fatigue. [1]
Healthy-volunteer tasks
Another study evaluated laboratory performance in healthy volunteers under mental fatigue. Such task outcomes are narrower than sustained improvement in daily function or treatment of a medical cause of fatigue. [2]
What remains unknown
Independent replication, modern diagnostic applicability, long-term safety, and interactions with psychiatric medications require further evidence.
Safety
Short follow-up cannot exclude dependence
The neurasthenia study included brief observation after stopping treatment. An absence of withdrawal in that setting is not proof that dependence or other problems are impossible with other exposures. [1]
Different delivery methods need their own evidence
The cited Ladasten studies cannot establish equivalence for newly marketed sprays or other preparations with different delivery characteristics. [2]
Understanding product quality
Compounded drugs are not FDA-approved finished products. Poor preparation can cause contamination or incorrect strength. A catalog entry or a research paper is not a quality assessment of your product. [3]
When to seek urgent help
Severe allergic symptoms such as trouble breathing, throat or tongue swelling, or fainting need immediate help. Call 911 or your local emergency number. This is general emergency information, not a complete list of risks for this compound. [4]
A starting point for discussion
This is not a complete list of adverse effects or interactions. Your health history, other medicines, and the exact formulation matter. Missing safety data is not evidence of safety.
Common questions
Can fatigue be treated without finding its cause?
These studies do not answer that. Persistent fatigue can require clinical assessment; the reported study population should not be treated as equivalent to every person with low energy.
Questions for your clinician
Does the evidence match my condition and this exact product? What risks or interactions matter for me? How would we assess whether it is helping?
Sources
- Ladasten compared with placebo for neurasthenia2009 · Original research · PubMed
- Ladasten in healthy volunteer laboratory tasks2009 · Original research · PubMed
- Compounding and the FDA: Questions and AnswersFDA · product quality and regulation
- AnaphylaxisMedlinePlus · recognizing an emergency
Educational information, not a recommendation to use a compound. Kairo does not give dosing advice. Review decisions with a licensed healthcare professional.